Bausch Health (MEX:BHCN) Days Inventory: 199.54 (As of Mar. 2026) — 23% Above Median


MEX:BHCN Bausch Health Companies Inc MEX:BHCN
48 GF Score
Price MXN85.44
GF Value MXN188.23
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Days Inventory?

Bausch Health MEX:BHCN 48 Days Inventory is 199.54 as of Mar. 2026, which is 23% above its 10-year median of 162.23. GuruFocus rates MEX:BHCN with a GF Score™ of 48/100 and a GF Value™ of MXN188.23 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 919 Drug Manufacturers companies, Bausch Health ranks worse than 62.57% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Bausch Health's Average Total Inventories for the three months ended in Mar. 2026 was MXN29,101 Mil. Bausch Health's Cost of Goods Sold for the three months ended in Mar. 2026 was MXN13,308 Mil. Hence, Bausch Health's Days Inventory for the three months ended in Mar. 2026 was 199.54.

The historical rank and industry rank for Bausch Health's Days Inventory or its related term are showing as below:

MEX:BHCN' s Days Inventory Range Over the Past 10 Years
Min: 149.82   Med: 162.23   Max: 200.01
Current: 195.45

During the past 13 years, Bausch Health's highest Days Inventory was 200.01. The lowest was 149.82. And the median was 162.23.

MEX:BHCN's Days Inventory is ranked worse than
62.57% of 919 companies
in the Drug Manufacturers industry
Industry Median: 162.83 vs MEX:BHCN: 195.45

Bausch Health's Days Inventory declined from Mar. 2025 (210.81) to Mar. 2026 (199.54).

Inventory Turnover measures how fast the company turns over its inventory within a year. Bausch Health's Inventory Turnover for the three months ended in Mar. 2026 was 0.46.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bausch Health's Inventory-to-Revenue for the three months ended in Mar. 2026 was 0.64.


Bausch Health  (MEX:BHCN) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Bausch Health's Inventory Turnover for the three months ended in Mar. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Bausch Health's Inventory to Revenue for the three months ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=29100.819 / 45514.535
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Bausch Health Days Inventory Related Terms


Bausch Health Days Inventory Historical Data

* Premium members only.

The historical data trend for Bausch Health's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Days Inventory Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 156.57 164.81 199.40 187.07 210.57

Bausch Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 210.81 203.49 200.55 186.22 199.54

MEX:BHCN vs ZTS: Days Inventory Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health Days Inventory vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Days Inventory distribution charts can be found below:

* The bar in red indicates where Bausch Health's Days Inventory falls into.


MEX:BHCN
48GF Score
Bausch Health Companies Inc MEX:BHCN
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Bausch Health's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (33264.841 + 29331.285) / 2 ) / 54251.174*365
=31298.063 / 54251.174*365
=210.57

Bausch Health's Days Inventory for the quarter that ended in Mar. 2026 is calculated as:

Days Inventory (Q: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (29331.285 + 28870.353) / 2 ) / 13308.133*365 / 4
=29100.819 / 13308.133*365 / 4
=199.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 199.54 mean?
Bausch Health (MEX:BHCN) has a Days Inventory of 199.54 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bausch Health and its competitors. This is 23% above median its historical median of 162.23. Over the past decade, Bausch Health's Days Inventory has ranged from 149.82 to 200.01. According to the industry distribution chart, Bausch Health ranks #575 out of 919 companies in the Drug Manufacturers industry, placing it in the top 62.6%.
Is Bausch Health's Days Inventory too high?
Bausch Health's current Days Inventory of 199.54 is 23% above median its 10-year median of 162.23. Over the past 10 years, this metric has ranged from a low of 149.82 to a high of 200.01. The Drug Manufacturers industry median Days Inventory is 162.83. Bausch Health's value of 199.54 is 22.5% above this industry median. Based on the distribution chart, Bausch Health ranks #575 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Bausch Health has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Bausch Health ranks #575 out of 919 companies for Days Inventory. This places Bausch Health in the lower half of its industry. The industry median Days Inventory is 162.83. Bausch Health's value of 199.54 is 22.5% above this benchmark. Historically, Bausch Health's own Days Inventory has ranged from 149.82 to 200.01 over the past decade. While the company's 10-year median is 162.23 vs. the industry median of 162.83, Bausch Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bausch Health's current Days Inventory of 199.54 is 22.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bausch Health and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bausch Health's current Days Inventory is 199.54, which is 23% above median its own 10-year median of 162.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (MEX:BHCN) is currently considered Possible Value Trap. The stock's GF Value™ is MXN188.23, compared to a current price of MXN85.44 — trading 54.6% below its estimated fair value. The current Days Inventory is 199.54, which is 23% above median its 10-year median of 162.23 and 22.5% above the Drug Manufacturers industry median of 162.83. Bausch Health's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bausch Health (MEX:BHCN), the current Days Inventory is 199.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (MEX:BHCN) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of MXN85.44 is trading 54.6% below its estimated GF Value™ of MXN188.23. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for MEX:BHCN:

  • Days Inventory: 199.54 (23% above median its 10-year median of 162.23)
  • GF Value™: MXN188.23 vs. price of MXN85.44 (54.6% below fair value)
  • GF Score™: 48/100 with 3 warning signs
  • Industry Position: 22.5% above the Drug Manufacturers median (#575 of 919)

No single metric tells the full story. See the MEX:BHCN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
48GF Score

Get the complete analysis for MEX:BHCN

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN85.44
Price
MXN188.23
GF Value